Next Article in Journal
Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Nivolumab vs. Pembrolizumab in Resectable Non-Small Cell Lung Cancer: A Systematic Review
Next Article in Special Issue
Language of the Heart: Creating Digital Stories and Found Poetry to Understand Patients’ Experiences Living with Advanced Cancer
Previous Article in Journal
Timely Treatment and No Change in Thyroid Cancer Mortality During COVID-19 Pandemic. Reply to Nocini et al. No Impact of COVID-19 Pandemic on Early Mortality for Thyroid Cancer in the US. Comment on “Lee et al. Impact of the COVID-19 Pandemic on Thyroid Cancer Surgery. Curr. Oncol. 2024, 31, 3579–3590”
 
 
Article

Article Versions Notes

Curr. Oncol. 2024, 31(10), 6272-6288; https://doi.org/10.3390/curroncol31100468
Action Date Notes Link
article html file updated 14 September 2025 03:25 CEST Update https://www.mdpi.com/1718-7729/31/10/468/html
article html file updated 25 August 2025 02:52 CEST Update -
article html file updated 27 June 2025 20:34 CEST Update -
article html file updated 18 October 2024 12:16 CEST Original file -
article pdf uploaded. 18 October 2024 12:14 CEST Version of Record https://www.mdpi.com/1718-7729/31/10/468/pdf
article xml uploaded. 18 October 2024 12:14 CEST Update https://www.mdpi.com/1718-7729/31/10/468/xml
article xml file uploaded 18 October 2024 12:14 CEST Original file -
Back to TopTop